SLC2A4 and inherited fatty acid metabolism disorder: In addition, BCW treatment can relieve glucose and fatty acid metabolism disorder through upregulation of CPT-1α, CS, and acetyl-CoA and downregulation of GLUT4, PFK, and pyruvate, which result in decreased FFA and LD levels and increased aerobic oxidation.